Retinal toxicity after cisplatin-based chemotherapy in patients with germ cell cancer. 2017

Simon Dulz, and Niels H Asselborn, and Klaus-Peter Dieckmann, and Cord Matthies, and Walter Wagner, and Jens Weidmann, and Christoph Seidel, and Christoph Oing, and Lars A Berger, and Winfried Alsdorf, and Blanche Mankichian, and Christian Meyer, and Malte W Vetterlein, and Philipp Gild, and Tim A Ludwig, and Armin Soave, and Philipp Schriefer, and Andreas Becker, and Sascha A Ahyai, and Karin Oechsle, and Carsten Bokemeyer, and Lars Wagenfeld, and Margit Fisch, and Michael Hartmann, and Felix K-H Chun, and Luis A Kluth
Department of Ophthalmology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

OBJECTIVE Visual impairment represents an infrequent form of cisplatin-induced neurotoxicity; however, visual deterioration has been reported in several studies. To evaluate potential morphological and functional retinal alterations in patients with germ cell cancer (GCC) treated with cisplatin-based chemotherapy (CBC). METHODS Multi-disciplinary and multi-institutional study design. Examination of 28 eyes of 14 male GCC patients, who had received at least one cycle of CBC. A matched control group of healthy, untreated patients were included in this study. Subjects underwent a retinal nerve fiber thickness (RNFL) measurement, color vision, visual acuity testing, full-field electroretinograms (ff-ERG). To assess a correlation between cumulative cisplatin dose and measured RNFL and ff-ERG Pearson correlation coefficient analysis was performed. RESULTS Both study groups (CBC recipients vs. healthy controls) consisted each of 14 participants with a median patient age of 30 years (interquartile range (IQR) 26-37 years). Tumor histology was seminoma in 6 of 14 patients (43%), and non-seminomatous GCC in 8 of 14 patients (57%). Median cumulative cisplatin dosis at examination was 627 mg/m2 (IQR 413-1013 mg/m2). Morphological assessment revealed reduced RNFL in 11 of 14 patients (78.6%). Reduction in RNFL was significantly correlated to the cumulative CBC dose received (rho = + 0.70; p = 0.004). ff-ERG showed significant differences between CBC recipients and the control group in 2 of 5 tested categories (all p values <0.001). CONCLUSIONS This study represents first evidence of chronic subclinical retinal toxicity due to cisplatin-based chemotherapy in patients with GCC. The reduction of RNFL might become clinically relevant in upcoming age-related chronic degenerative disorders such as glaucoma.

UI MeSH Term Description Entries
D008297 Male Males
D009373 Neoplasms, Germ Cell and Embryonal Neoplasms composed of primordial GERM CELLS of embryonic GONADS or of elements of the germ layers of the EMBRYO, MAMMALIAN. The concept does not refer to neoplasms located in the gonads or present in an embryo or FETUS. Germ Cell Cancer,Germ Cell Tumor,Neoplasms, Embryonal and Mixed,Cancer, Embryonal,Cancer, Embryonal and Mixed,Embryonal Neoplasms,Germ Cell Neoplasms,Germ Cell and Embryonal Neoplasms,Germ Cell and Embryonic Neoplasms,Neoplasms, Embryonal,Neoplasms, Germ Cell,Neoplasms, Germ Cell and Embryonic,Cancer, Germ Cell,Cancers, Embryonal,Cancers, Germ Cell,Embryonal Cancer,Embryonal Cancers,Embryonal Neoplasm,Germ Cell Cancers,Germ Cell Tumors,Neoplasm, Embryonal,Tumor, Germ Cell,Tumors, Germ Cell
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D012160 Retina The ten-layered nervous tissue membrane of the eye. It is continuous with the OPTIC NERVE and receives images of external objects and transmits visual impulses to the brain. Its outer surface is in contact with the CHOROID and the inner surface with the VITREOUS BODY. The outer-most layer is pigmented, whereas the inner nine layers are transparent. Ora Serrata
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004596 Electroretinography Recording of electric potentials in the retina after stimulation by light. Electroretinographies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013736 Testicular Neoplasms Tumors or cancer of the TESTIS. Germ cell tumors (GERMINOMA) of the testis constitute 95% of all testicular neoplasms. Cancer of Testis,Cancer of the Testes,Testicular Cancer,Testicular Neoplasm,Testicular Tumor,Testis Cancer,Cancer of the Testis,Neoplasms, Testicular,Neoplasms, Testis,Testicular Tumors,Testis Neoplasms,Tumor of Rete Testis,Cancer, Testicular,Cancer, Testis,Cancers, Testicular,Cancers, Testis,Neoplasm, Testicular,Neoplasm, Testis,Rete Testis Tumor,Rete Testis Tumors,Testicular Cancers,Testis Cancers,Testis Neoplasm,Testis Tumor, Rete,Testis Tumors, Rete,Tumor, Testicular,Tumors, Testicular

Related Publications

Simon Dulz, and Niels H Asselborn, and Klaus-Peter Dieckmann, and Cord Matthies, and Walter Wagner, and Jens Weidmann, and Christoph Seidel, and Christoph Oing, and Lars A Berger, and Winfried Alsdorf, and Blanche Mankichian, and Christian Meyer, and Malte W Vetterlein, and Philipp Gild, and Tim A Ludwig, and Armin Soave, and Philipp Schriefer, and Andreas Becker, and Sascha A Ahyai, and Karin Oechsle, and Carsten Bokemeyer, and Lars Wagenfeld, and Margit Fisch, and Michael Hartmann, and Felix K-H Chun, and Luis A Kluth
December 2011, Anticancer research,
Simon Dulz, and Niels H Asselborn, and Klaus-Peter Dieckmann, and Cord Matthies, and Walter Wagner, and Jens Weidmann, and Christoph Seidel, and Christoph Oing, and Lars A Berger, and Winfried Alsdorf, and Blanche Mankichian, and Christian Meyer, and Malte W Vetterlein, and Philipp Gild, and Tim A Ludwig, and Armin Soave, and Philipp Schriefer, and Andreas Becker, and Sascha A Ahyai, and Karin Oechsle, and Carsten Bokemeyer, and Lars Wagenfeld, and Margit Fisch, and Michael Hartmann, and Felix K-H Chun, and Luis A Kluth
September 1997, The Journal of urology,
Simon Dulz, and Niels H Asselborn, and Klaus-Peter Dieckmann, and Cord Matthies, and Walter Wagner, and Jens Weidmann, and Christoph Seidel, and Christoph Oing, and Lars A Berger, and Winfried Alsdorf, and Blanche Mankichian, and Christian Meyer, and Malte W Vetterlein, and Philipp Gild, and Tim A Ludwig, and Armin Soave, and Philipp Schriefer, and Andreas Becker, and Sascha A Ahyai, and Karin Oechsle, and Carsten Bokemeyer, and Lars Wagenfeld, and Margit Fisch, and Michael Hartmann, and Felix K-H Chun, and Luis A Kluth
December 1999, Annals of oncology : official journal of the European Society for Medical Oncology,
Simon Dulz, and Niels H Asselborn, and Klaus-Peter Dieckmann, and Cord Matthies, and Walter Wagner, and Jens Weidmann, and Christoph Seidel, and Christoph Oing, and Lars A Berger, and Winfried Alsdorf, and Blanche Mankichian, and Christian Meyer, and Malte W Vetterlein, and Philipp Gild, and Tim A Ludwig, and Armin Soave, and Philipp Schriefer, and Andreas Becker, and Sascha A Ahyai, and Karin Oechsle, and Carsten Bokemeyer, and Lars Wagenfeld, and Margit Fisch, and Michael Hartmann, and Felix K-H Chun, and Luis A Kluth
January 1997, Annals of oncology : official journal of the European Society for Medical Oncology,
Simon Dulz, and Niels H Asselborn, and Klaus-Peter Dieckmann, and Cord Matthies, and Walter Wagner, and Jens Weidmann, and Christoph Seidel, and Christoph Oing, and Lars A Berger, and Winfried Alsdorf, and Blanche Mankichian, and Christian Meyer, and Malte W Vetterlein, and Philipp Gild, and Tim A Ludwig, and Armin Soave, and Philipp Schriefer, and Andreas Becker, and Sascha A Ahyai, and Karin Oechsle, and Carsten Bokemeyer, and Lars Wagenfeld, and Margit Fisch, and Michael Hartmann, and Felix K-H Chun, and Luis A Kluth
January 1994, European urology,
Simon Dulz, and Niels H Asselborn, and Klaus-Peter Dieckmann, and Cord Matthies, and Walter Wagner, and Jens Weidmann, and Christoph Seidel, and Christoph Oing, and Lars A Berger, and Winfried Alsdorf, and Blanche Mankichian, and Christian Meyer, and Malte W Vetterlein, and Philipp Gild, and Tim A Ludwig, and Armin Soave, and Philipp Schriefer, and Andreas Becker, and Sascha A Ahyai, and Karin Oechsle, and Carsten Bokemeyer, and Lars Wagenfeld, and Margit Fisch, and Michael Hartmann, and Felix K-H Chun, and Luis A Kluth
January 2009, Acta oncologica (Stockholm, Sweden),
Simon Dulz, and Niels H Asselborn, and Klaus-Peter Dieckmann, and Cord Matthies, and Walter Wagner, and Jens Weidmann, and Christoph Seidel, and Christoph Oing, and Lars A Berger, and Winfried Alsdorf, and Blanche Mankichian, and Christian Meyer, and Malte W Vetterlein, and Philipp Gild, and Tim A Ludwig, and Armin Soave, and Philipp Schriefer, and Andreas Becker, and Sascha A Ahyai, and Karin Oechsle, and Carsten Bokemeyer, and Lars Wagenfeld, and Margit Fisch, and Michael Hartmann, and Felix K-H Chun, and Luis A Kluth
January 1996, Acta oncologica (Stockholm, Sweden),
Simon Dulz, and Niels H Asselborn, and Klaus-Peter Dieckmann, and Cord Matthies, and Walter Wagner, and Jens Weidmann, and Christoph Seidel, and Christoph Oing, and Lars A Berger, and Winfried Alsdorf, and Blanche Mankichian, and Christian Meyer, and Malte W Vetterlein, and Philipp Gild, and Tim A Ludwig, and Armin Soave, and Philipp Schriefer, and Andreas Becker, and Sascha A Ahyai, and Karin Oechsle, and Carsten Bokemeyer, and Lars Wagenfeld, and Margit Fisch, and Michael Hartmann, and Felix K-H Chun, and Luis A Kluth
April 1994, Annals of oncology : official journal of the European Society for Medical Oncology,
Simon Dulz, and Niels H Asselborn, and Klaus-Peter Dieckmann, and Cord Matthies, and Walter Wagner, and Jens Weidmann, and Christoph Seidel, and Christoph Oing, and Lars A Berger, and Winfried Alsdorf, and Blanche Mankichian, and Christian Meyer, and Malte W Vetterlein, and Philipp Gild, and Tim A Ludwig, and Armin Soave, and Philipp Schriefer, and Andreas Becker, and Sascha A Ahyai, and Karin Oechsle, and Carsten Bokemeyer, and Lars Wagenfeld, and Margit Fisch, and Michael Hartmann, and Felix K-H Chun, and Luis A Kluth
January 1997, European urology,
Simon Dulz, and Niels H Asselborn, and Klaus-Peter Dieckmann, and Cord Matthies, and Walter Wagner, and Jens Weidmann, and Christoph Seidel, and Christoph Oing, and Lars A Berger, and Winfried Alsdorf, and Blanche Mankichian, and Christian Meyer, and Malte W Vetterlein, and Philipp Gild, and Tim A Ludwig, and Armin Soave, and Philipp Schriefer, and Andreas Becker, and Sascha A Ahyai, and Karin Oechsle, and Carsten Bokemeyer, and Lars Wagenfeld, and Margit Fisch, and Michael Hartmann, and Felix K-H Chun, and Luis A Kluth
July 1999, British journal of cancer,
Copied contents to your clipboard!